Oncolix, Inc. Deferred Offering Costs
Oncolix, Inc. had Deferred Offering Costs of $5.46 thousand as of 2018-09-30, per its 10-Q filed 2018-11-19.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2018-11-19
- 2018-09-30: Deferred Offering Costs $5.46K.
| Period end | Deferred Offering Costs |
|---|---|
| 2018-09-30 | $5.46K 10-Q · filed 2018-11-19 |